Thursday, May 08, 2008 9:39:34 AM
HONG KONG, May 8 /Xinhua-PRNewswire-FirstCall/ -- China Technology Development Group Corporation (NASDAQ:CTDC) ("CTDC" or "the Company"), a provider of clean and renewable energy products and solutions focusing on solar energy business in China, is pleased to announce that the engineering team of China Merchants Zhangzhou Development Zone Trenda Solar Energy Ltd. ("Trenda"), the wholly-owned subsidiary of the Company, has successfully concluded the testing of its first SnO2 production line. This line is expected to operate the pilot production of the solar base plates in June. SnO2 solar base plate is a type of transparent conductive oxide substrate of amorphous silicon (a-Si) or thin film solar cells. It is a key component of a-Si thin film PV products which optimizes the performance of Building Integrated Photovoltaics (BIPV).
The dedicated engineers from our company and our US and China partners, Terra Solar & China Solar, have been working diligently in the past several months to enhance the manufacturing techniques in order to maximize the energy efficiency as well as to minimize the production cost of the SnO2 base plate product. Commercial production is expected to ramp up to full production within 6 months.
"We are delighted to announce the test completion of the first production line and are excited about the upcoming milestones according to our expansion plan. The test completion timeline of the first production line is consistent with the Company's strategy plan announced in December of 2007. We have initiated meetings with our potential customers concerning our product availability and delivery schedule. We are confident that our final product will be well qualified and competitive to meet the increasing demands for our product in the upcoming months," commented by Alan Li, Chairman and Chief Executive Officer of the Company.
last: 5.32 +0.31 (+6.19%)
Solar Stocks #board-11148
Peak Oil #board-6609
Coal #board-2809
Real Estate Bubble #board-7285
Lender Implosion #board-10076
HomeBuilders #board-1680
Your Economy #board-1948
Global Warming #board-11877
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM